General MedicationsORALStandard
ANAFRANIL
CLOMIPRAMINE HYDROCHLORIDE
Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: 901 REQUIRED Marketing status: Prescription
Summary
Approval overview ANAFRANIL is listed in Drugs@FDA under application 019906 (NDA).
Review priority: 901 REQUIRED Marketing status: Prescription Active ingredient CLOMIPRAMINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 50MG Sponsor SPECGX LLC Submission history Latest submission status date: 2019-05-10 00:00:00.
Structured Monograph
Clinical summary
Approval overview ANAFRANIL is listed in Drugs@FDA under application 019906 (NDA). Review priority: 901 REQUIRED Marketing status: Prescription Active ingredient CLOMIPRAMINE HYDROCHLORIDE Form and strength CAPSULE;ORAL - 50MG Sponsor SPECGX LLC Submission history Latest submission status date: 2019-05-10 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: 901 REQUIRED
Interaction Notes
- No interaction notes stored yet.